Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?CHIU, Chao-Hua; CHOU, Teh-Ying; CHIANG, Chi-Lu et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 661-665, issn 0344-5704, 5 p.Article

Erlotinib in patients with advanced lung squamous cell carcinomaCHIANG, Chi-Lu; TSAI, Chun-Ming; CHOU, Teh-Ying et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 203-208, issn 0344-5704, 6 p.Article